FLORENCE, S.C., Dec. 18, 2015 (GLOBE NEWSWIRE) -- DeGen Medical has received clearance from the FDA for our cervical interbody fusion device - Latitude-C™ Cervical Interbody Spacer System. Latitude-C™ Cervical Interbody Spacer offers the surgeon a wide variety of materials based on patient needs – PEEK-OPTIMA®, Porous Titanium with PEEK, PEEK-OPTIMA® HA Enhanced, Titanium and Carbon fiber-reinforced (CFR) PEEK-OPTIMA®.
|
|||||
The Latitude-C™ Cervical Interbody Spacer is unique, patent pending design considers the uncinate process of the cervical vertebra. The lateral angles of the Latitude-C™ cervical spacer device are unique to match individual patient anatomy and different angles allow for perfect fit at every fusion level.
"The Latitude-C™ graft is a tectonic shift away from traditional rectangular shape cervical grafts. The trapezoidal shape is tremendous improvement in respecting the correct anatomy of patients," says Dr.Chokshi at Pee Dee Spine Center, Florence, SC.
The Latitude-C™ Cervical Interbody fusion devices come in variety of shapes and sizes:
- 5 different footprints from 12x12mm to 20x15mm and each size has 10 heights - 5 to 14mm
- There are 3 different shape options to choose from – Anatomic, Lordotic and Parallel
- The system is delivered in several color coded options for procedural flexibility
The Latitude-C™ interbody fusion devices will be available in Q1 of 2016.
About DeGen Medical, Inc.
DeGen Medical, Inc. is a medical-device development company dedicated to providing surgeons with innovative products engineered to improve quality of life for patients with complex spinal disorders. World-class implants, coupled with intuitively-designed instrumentation, provide a complete package to promote superior surgical outcomes. Our passion to advance spine-care solutions is driven by clinical insights, sound research, and science-based design. DeGen Medical maintains the highest quality standards to provide reliable products and safeguard patient health.
A photo accompanying this release is available at: http://www.globenewswire.com/newsroom/prs/?pkgid=38239
CONTACT: Jessica Clark
DeGen Medical, Inc.
Phone: 877-240-7838
www.DeGenmedical.com


Yaskawa Electric Shares Slide as Weak Profit Overshadows Strong AI Demand
Apple Sues OpenAI, Former Employees Over Alleged Trade Secret Theft
SK Hynix Soars 13% in Nasdaq Debut After Record $26.5 Billion IPO
Fast Retailing Raises Full-Year Forecast After Uniqlo Owner Beats Q3 Profit Estimates
Muji Owner Ryohin Keikaku Stock Soars After Raising Full-Year Earnings Forecast
Samsung Chairman Lee Jae-yong Expected to Meet Nvidia CEO Jensen Huang on AI and Chip Partnership
UBS Starts CarTrade Tech With Buy Rating, Sees Strong Earnings Growth and ₹4,000 Target
Stellantis Q2 Vehicle Shipments Rise 10% as North America Drives Growth
Deutsche Bank Fined A$2 Million by ASIC Over OTC Derivatives Reporting Errors
AstraZeneca Shares Sink After Wainua Trial Misses Key Heart Disease Goal
OpenAI Executive Fidji Simo to Step Down Amid Health Challenges Ahead of IPO
Australia Flags Child Safety Gaps at Apple, Meta, Google Over Online Sexual Extortion
Samsung to Launch First Yongin Chip Plant by 2029 as South Korea Speeds Up Semiconductor Hub
SK Hynix Prices Record U.S. ADR Offering at $149 After $200 Billion Investor Demand
DOJ Grand Jury Investigates UAW President Shawn Fain Ahead of Union Election
Goldman AM Sees Strong Buyout Opportunities in Japan, South Korea and Australia
Elon Musk Says Anthropic Leads AI Race as Claude Models Challenge OpenAI 



